-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Buy on Cardinal Health, Raises Price Target to $309

Benzinga·11/12/2026 14:01:06
Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $264 to $309.